Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Dai Chihara, Jason R. Westin, Roberto N. Miranda, Chan Y. Cheah, Yasuhiro Oki, Francesco Turturro, Jorge E. Romaguera, Sattva S. Neelapu, Lorreta J. Nastoupil, Luis E. Fayad, M. Alma Rodriguez, Nathan H. Fowler, Robert Z. Orlowski, Michael Wang, Fredrick B. Hagemeister, L. Jeffrey Medeiros, Michelle A. Fanale